These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Aryl-2-halogenoalkylamines. XXII. Derivatives of phenoxyacetic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):873-82. PubMed ID: 5661350 [No Abstract] [Full Text] [Related]
9. 2,2'-(9,10-anthrylenedimethylene)bis[2-thiopseudourea], dihydrochloride, dihydrate (NSC-56054)--clinical brochure. Carter SK Cancer Chemother Rep 3; 1968 Dec; 1(1):153-63. PubMed ID: 4989812 [No Abstract] [Full Text] [Related]
10. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151). Woodman RJ Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499 [No Abstract] [Full Text] [Related]
11. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure. Carter SK; Newman JW Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773 [No Abstract] [Full Text] [Related]
12. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351 [No Abstract] [Full Text] [Related]
13. Screening study on Taiwan plants for antitumor activities. King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546 [No Abstract] [Full Text] [Related]
14. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352 [No Abstract] [Full Text] [Related]
15. Chemotherapy research nurse. Hubbard S; Devita V Am J Nurs; 1976 Apr; 76(4):560-5. PubMed ID: 818899 [No Abstract] [Full Text] [Related]
16. Potential carcinolytic agents. VII. Substituted bis(2-methanesulfonoxyethyl)anilines. Papanastassiou ZB; Bruni RJ; Estes PB; Wodinsky I J Med Chem; 1969 Sep; 12(5):825-8. PubMed ID: 5818089 [No Abstract] [Full Text] [Related]
17. Some organoboron compounds containing a bis(2-chloroethyl)amino group joined to boron. Shealy YF; Struck RF J Med Chem; 1969 Sep; 12(5):907-11. PubMed ID: 5812211 [No Abstract] [Full Text] [Related]
18. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors. Mihich E; Nichol CA Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028 [No Abstract] [Full Text] [Related]
19. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457 [No Abstract] [Full Text] [Related]
20. Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188). DeWys WD; Hall TC Cancer Chemother Rep; 1973 Feb; 57(1):41-9. PubMed ID: 4704102 [No Abstract] [Full Text] [Related] [Next] [New Search]